Jan Pinkas

Direttore Tecnico/Scientifico/R&S presso PYXIS ONCOLOGY, INC.

Health Technology

Consumer Services

Posizioni attive di Jan Pinkas

Società	Posizione	Inizio	Fine
PYXIS ONCOLOGY, INC.	Direttore Tecnico/Scientifico/R&S	12/04/2022	-
PYXIS ONCOLOGY, INC.	Corporate Officer/Principal	01/08/2021	12/04/2022

Società	Posizione	Inizio	Fine
IMMUNOGEN, INC.	Corporate Officer/Principal	-	-
MAGENTA THERAPEUTICS	Corporate Officer/Principal	-	-

University of Massachusetts	Doctorate Degree
The Johns Hopkins University	Undergraduate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Corporate Officer/Principal	3
Chief Tech/Sci/R&D Officer	1
Doctorate Degree	1

Settori

Health Technology	4
Consumer Services	3

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
PYXIS ONCOLOGY, INC.	Health Technology

Aziende private	2
Magenta Therapeutics, Inc. Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA.	Health Technology
ImmunoGen, Inc. ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA.	Health Technology

Aziende private

Health Technology